Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07012512
NA

Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in Children

Sponsor: Mansoura University

View on ClinicalTrials.gov

Summary

The study aims at reversing pupillary dilatation. and cycloplegia in children undergoing cycloplegic refraction for eyeglasses prescription and ocular examination. This will be achieved using pilocarpine , phentolamine or a combination. This may help decrease the glare and improve near vision early to decrease unwanted effects of cycloplegic drops.

Key Details

Gender

All

Age Range

5 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-06-01

Completion Date

2025-12-30

Last Updated

2025-06-10

Healthy Volunteers

No

Interventions

DRUG

Use of phentolamine eye drops to reverse cycloplegia

Use of phentolamine 0.75% eye drops to reverse cycloplegia

DRUG

Pilocarpine 0.1%

Use of pilocarpine 0.1% to reverse cycloplegia

DRUG

Combination of pilocarpine 0.1% and phentolamine 0.75%

Combination of pilocarpine 0.1% and phentolamine 0.75%